Page 191 - Read Online

Saneto. J Transl Genet Genom 2020;4:384-428 I http://dx.doi.org/10.20517/jtgg.2020.40 Page 419

78. Tamiya G, Makino S, Hayshi M, Abe A, Numakura C, et al. A mutation of COX64A1 causes recessive axonal or mixed form of Charcot-
Marie-Tooth disease. Am J Hum Genet 2014;95:294-300.
79. Signes A, Cerutti R, Dickson AS, Beninca C, Hinchy EC, et al. APOTP1/COA8 assembly and is oppositely regulated by UPS and ROS.
EMBO Mol Med 2019;11:e9582.
80. Melchionda L, Haack TB, Hardy S, Abbink TEM, Fernandez-Vizarra E, et al. Mutations in APOPT1, encoding a mitochondrial protein,
cause cavitating leukoencephalopthy with cytochrome c oxidase deficiency. Am J Hum Genet 2014;95:315-25.
81. Jonckheere AI, Smeitink JAM, Rodenburg RJT. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis
2011;35:211-25.
82. Akagi M, Inui K, Tsukamoto H, Sakai N, Muramatsu T, et al. A point mutation of mitochondrial ATPase 6 gene in Leigh syndrome.
Neuromuscul Disord 2002;12:53-5.
83. Holt TJ, Harding AE, Petty RKH, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
Am J Hum Genet 1990;46:428-33.
84. Stendel C. Neuhofer C, Floride E, Yuqing S, Ganetzky RD, et al. Delineating MT-ATP6-associated disease: From isolated neuropathy to
early onset neurodegeneration. Neurol Genet 2020;6:e393.
85. Mayr JA, Havlickova V, Zimmermann F, Magler I, Kaplanova V, et al. Mitochondrial ATP synthase deficiency due to a mutation in the
ATP5E gene for the F1 e subunit. Hum Mol Genet 2010;19:3430-9.
86. Spiegel R, Khayat M, Shalev SA. Horovitz Y, Mandel H, et al. TMEM70 mutations are a common cause of nuclear encoded ATP synthase
assembly defect: further delineation of a new syndrome. J Med Genet 2011;48:177-82.
87. Siegmund SE, Grassucci R, Carter SD, Barca E, Farino ZJ, et al. Three-dimensional analysis of mitochondrial crista ultrastructure in a
patient with Leigh syndrome by in situ cryoelectron tomography. iScience 2018;6:83-91.
88. Barca E, Ganetzky RD, Potluri P, Juanola-Falgarona M, Gai X, et al. USMG5 Ashkenazi Jewish founder mutations impairs mitochondrial
complex V dimerization and ATP synthesis. Hum Mol Genet 2018;27:3305-12.
89. Sofou K, De Coo IFM, Isohanni P, Ostergaard E, Naess K, et al. A multicenter study on Leigh syndrome: disease course and predictions
on survival. Orphan J Rare Dis 2014;9:52.
90. Rahman S, Blok RB, Dahl HHM, Danks DM, Kirby DM, et al. Leigh syndrome. Clinical features and biochemical and DNA
abnormalities. Ann Neurol 1996;39:343-51.
91. Ruhoy IS, Saneto RP. The genetics of Leigh syndrome and its implication for clinical practice and risk management. The App Clin Genet
2014;7:221-34.
92. McKelvie P, Infeld B, Marotta R, Chin J, Thorburn D, et al. Late-adult onset Leigh syndrome. J Clin Neurosci 2012;19:195-202.
93. Saneto RP, Friedman SD, Shaw DWW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396-413.
94. Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004;1660:171-99.
95. Trevisson E, DiMauro S, Vavas P, Salvati L. Coenzyme Q deficiency in muscle. Curr Opinion in Neurol 2011;24:440-56.
96. Desbats MA, Lunardi G, Doimo M, Trevisson E, Salviati L. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ10)
deficiency. J Inherit Metab Dis 2015;38:145-56.
97. Babbitt SE, Sutherland MC, San Francisco B, Mendez DL, Kranz RG. Mitochondrial cytochrome c biogenesis: no longer an enigma.
Trends Biochem Sci 2015;40:446-55.
98. Wimplinger I, Morleo M, Rosenberger G, Iaconis D, Orth U, et al. Mutations of the mitochondrial holocytochrome c-type synthase in
X-linked dominant microphthalmia with linear skin defects syndrome. Am J Hum Genet 2006;79:878-89.
99. Uchiyama Y, Yanagisawa K, Dunishima S, Shina M, Ogawa Y, et al. A novel CYHCS mutation in the a-helix of the CYCS C-terminal
domain causes non-syndromic thrombocytopenia. Clin Genet 2018;94:548-53.
100. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 2008;9:532-42.
101. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, et al. A direct repeat is a hotspot for large-scale deletion of human mitochondrial
DNA. Science 1989;144:346-9.
102. Sadikovic B, Wang J, El-Hattab A, Landsverk M, Douglas G, et al. Sequence homology at the breakpoint and clinical phenotype of
mitochondrial DNA deletion syndromes. PLoS One 2010;5:e15687.
103. Chen X, Prosser R, Simonetti S, Sadlock J, Jagiello G, et al. Rearranged mitochondrial genomes are present in human oocytes. Am J Hum
Genet 1995;57:239-47.
104. Hayashi JI, Ohta S, Kikuchi A, Takemitsu M, Goto Y, et al. Introduction of disease-related mitochondrial DNA deletions into HeLa cells
lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 1991;88:10614-8.
105. Gustafson MA, McCormick EM, Perera L, Longley MJ, Bai R, et al. Mitochondrial single-stranded DNA binding protein novel de novo
SSBP1 mutation in a child with single large-scale mtDNA deletion (SLSMD) clinically manifesting as Pearson, Kearns-Sayre, and Leigh
syndromes. PLoS One 2019;14:e0221829.
106. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, et al. Maternally transmitted partial direct tandem duplication of
mitochondrial DNA associated with diabetes mellitus. Hum Mol Genet 1993;2:1619-24.
107. Pearson HA, Lobel JS, Kocoshis SA, Niaman JL, Windmiller J, et al. A new syndrome of refractory sideroblastic anemia with
vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 1979;95:976-84.
108. Rotig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, et al. Pearson’s marrow-pancreas syndrome: a multisystem mitochondrial
disorder in infancy. J Clin Invest 1990;86:1601-8.
109. Grady JP, Campbell G, Ratnaike T, Blakely EL, Falkous G, et al. Disease progression in patients with single large-scale mitochondrial
DNA deletions. Brain 2014;137:323-34.